Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 3039  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page
Year : 2003  |  Volume : 48  |  Issue : 1  |  Page : 27-29

Trial Of Ofloxacin In Paucibacillary Leprosy

Correspondence Address:
S K Sayal

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Sixty newly diagnosed cases of paucibacillary leprosy were studied for the efficacy of ofloxacin combined with rifampicin in the treatment of paucibacillary leprosy and to compare the combination with the standard WHO multidrug therapy (MDT). All patients were evaluated clinically and bacteriologically at the beginning and then monthly for six months. Histopathological correlation was present in 70% of the cases while divergence was seen in 30% cases. Clinically, at the end of one month there was significant improvement in the group which was treated with ofloxacin and rifampicin combination as compared to standard WHO multidrug therapy. However no significant difference among groups treated with ofloxacin, rifampicin combination or standard MDT was seen after 3 months or 6 months of treatment. There was also no significant difference whether ofloxacin and rifampicin were given for one month or three months

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded82    
    Comments [Add]    

Recommend this journal